Yini i-Brigatinib: Ukusetshenziswa, Umthamo, Imiphumela Eceleni nokuningi

I-Brigatinib iyikhambi lomdlavuza eliqondiswe ngqo elenzelwe ukwelapha uhlobo oluthile lomdlavuza wamaphaphu obizwa ngokuthi i-ALK-positive non-small cell lung cancer. Lo muthi oqokiwe usebenza ngokuvimba amaprotheni athile asiza amaseli omdlavuza ukuthi akhule futhi asakazeke emzimbeni wakho wonke.

Uma wena noma othile omkhathalelayo eqokiwe i-brigatinib, cishe ufuna ulwazi olucacile, oluthembekile mayelana nokuthi yini ongayilindela. Ake sihambe kukho konke okudingeka ukwazi ngalo muthi ngendlela ezizwa ilawuleka futhi iqinisekisa.

Yini i-Brigatinib?

I-Brigatinib ingeyodwa yohlobo lwemithi ebizwa ngokuthi ama-kinase inhibitors, okuyizindlela zokwelapha umdlavuza eziqondiswe ngqo. Cabanga ngayo njengethuluzi eliqondile kunokwelashwa okubanzi—iqondisa ngqo amaseli omdlavuza anoshintsho oluthile lofuzo olubizwa ngokuthi i-ALK rearrangement.

Lo muthi uza ngamaphilisi omlomo owathatha ngomlomo, okwenza kube lula kunezinye izindlela zokwelapha umdlavuza ezidinga ukuvakashelwa esibhedlela ukuze kufakwe. Umuthi wathuthukiswa ukuze usebenze kahle kumangqamuzana omdlavuza wamaphaphu asebe melana nezinye izithiyo ze-ALK.

Udokotela wakho we-oncologist ngokuvamile uzoqoka i-brigatinib ngemva kokuqinisekisa ngokuhlolwa kofuzo ukuthi umdlavuza wakho une-ALK gene rearrangement. Le ndlela yomuntu siqu isiza ekuqinisekiseni ukuthi uthola ukwelashwa okufanele kakhulu ohlotsheni lwakho oluthile lomdlavuza.

Isetshenziselwani i-Brigatinib?

I-Brigatinib isetshenziswa ikakhulukazi ukwelapha i-ALK-positive metastatic non-small cell lung cancer (NSCLC). Lokhu kusho ukuthi iqokiwe ngomdlavuza wamaphaphu oye wasakazekela kwezinye izingxenye zomzimba futhi oqukethe izinguquko ezithile zofuzo.

Udktela wakho angase akunikeze i-brigatinib njengokwelashwa kokuqala uma usanda kutholwa ukuthi unesifo somdlavuza wamaphaphu we-ALK-positive. Noma kunjalo, kungase kutuswe uma umdlavuza wakho usuthuthukile noma uyekile ukuphendula kwamanye ama-ALK inhibitors afana ne-crizotinib noma i-ceritinib.

Umuthi futhi ufundwa kwezinye izinhlobo zomdlavuza ezinoshintsho lwe-gene ye-ALK, nakuba lezi zinto zisathathwa njengezivivinyo. Udokotela wakho we-oncologist uzoqoka ukuthi i-brigatinib ilungele yini ngokuya ngohlobo lomdlavuza wakho oluthile nemiphumela yokuhlolwa kwezakhi zofuzo.

Isebenza Kanjani I-Brigatinib?

I-Brigatinib isebenza ngokuvimba iphrotheni ye-ALK, esebenza njengokushintsha okungalungile okutshela amaseli omdlavuza ukuthi akhule futhi aphindaphindeke ngokungapheli. Ngokuvimbela le phrotheni, umuthi empeleni ucisha isignali eqhuba ukukhula komdlavuza.

Lokhu kuthathwa njengokwelashwa okuqinile, okuhloswe ngakho ngoba kuhlasela ngokuqondile indlela ye-molecular eqhuba umdlavuza wakho. Ngokungafani ne-chemotherapy yendabuko ethinta amaseli anempilo nawomdlavuza, i-brigatinib yenzelwe ukuba ikhetheke kakhulu esenzweni sayo.

Umuthi futhi unomsebenzi wokulwa nezinguquko ezithile ezingavela lapho umdlavuza uba ngumelana namanye ama-ALK inhibitors. Lokhu kuyenza ibaluleke ikakhulukazi ekwelapheni imidlava eguqukele ekugwemeni ezinye izindlela zokwelapha ezihloswe ngazo.

Iziguli eziningi ziqala ukubona imiphumela emasontweni ambalwa okuqala kokwelashwa, nakuba inzuzo ephelele ingase ithathe izinyanga eziningana ukuba ibonakale ezifundweni zokucabanga.

Kufanele Ngiyithathe Kanjani I-Brigatinib?

Thatha i-brigatinib ngendlela udokotela wakho we-oncologist ayikunikeza ngayo, ngokuvamile kanye ngosuku ngokudla noma ngaphandle kokudla. Ungayithatha nengilazi yamanzi, futhi akukho sidingo esithile sokuyithatha nobisi noma ukugwema ukudla okuthile.

Gwinya amaphilisi wonke ngaphandle kokuwachoboza, ukuwahlafuna, noma ukuwaqhekeza. Uma unzima ukugwinya amaphilisi, khuluma neqembu lakho lezempilo mayelana namaqhinga angasiza, kodwa ungawashintshi amaphilisi uwedwa.

Zama ukuthatha i-brigatinib ngesikhathi esifanayo nsuku zonke ukuze ugcine amazinga aqhubekayo emzimbeni wakho. Iziguli eziningi zikuthola kusiza ukuxhuma ukuthatha imithi yazo emsebenzini wansuku zonke, njengokudla kwasekuseni noma ukuxubha amazinyo.

Akudingeki udle ukudla okuthile ngaphambi kokuthatha i-brigatinib, kodwa ukugcina ukudla okunempilo ngesikhathi sokwelashwa kwakho kungasiza ukusekela impilo yakho yonke namazinga amandla.

Kufanele Ngiyithathe Isikhathi Esingakanani I-Brigatinib?

Ngokuvamile uzoqhubeka nokuthatha i-brigatinib uma nje ilawula ngempumelelo umdlavuza wakho futhi uyayibekezelela kahle. Lokhu kungaba izinyanga noma iminyaka, kuye ngokuthi umdlavuza wakho usabela kanjani ekwelashweni.

Udokotela wakho we-oncologist uzoqapha inqubekela phambili yakho ngokuskena njalo nokuhlolwa kwegazi ukuze anqume ukuthi imithi iyasebenza yini ngempumelelo. Lokhu kuhlolwa kuvame ukwenzeka njalo ezinyangeni ezimbalwa, nakuba isimiso singahluka ngokuya ngesimo sakho.

Ezinye iziguli ziqhubeka ne-brigatinib isikhathi eside ngokulawulwa okuhle komdlavuza nemiphumela emibi elawulekayo. Abanye bangase badinge ukulungisa uhlelo lwabo lokwelashwa uma umdlavuza ukhula noma uma imiphumela emibi iba yinkinga.

Ungayeki ukuthatha i-brigatinib ngaphandle kokuxoxa ngayo neqembu lakho lezempilo kuqala. Noma ngabe uzizwa kahle, ukuyeka kungazelelwe kungavumela umdlavuza wakho ukuthi ukhule ngokushesha.

Yiziphi Imiphumela Emibi Ye-Brigatinib?

Njengayo yonke imithi yomdlavuza, i-brigatinib ingabangela imiphumela emibi, nakuba iziguli eziningi zizithola zilawuleka ngosekelo olufanele nokuqapha. Ukuqonda okukulindele kungakusiza ukuthi uzizwe ulungiseleleke futhi uqiniseke ngokwelashwa kwakho.

Nawa imiphumela emibi evame kakhulu iziguli ezihlangabezana nayo, ethinta ngaphezu kuka-20% wabantu abathatha i-brigatinib:

• Ukuqunjelwa, okuvame ukuphathwa ngokushintsha ukudla nemithi
• Ukukhathala noma ukuzizwa ukhathele kunokujwayelekile
• Isicanucanu, esivame ukuphathwa ngemithi elwa nesicanucanu
• Ikhanda, ngokuvamile elilula noma eliphakathi nendawo
• Ukhwehlela, okungase kuhlobane nesimo sakho samaphaphu noma imithi
• Ubuhlungu bemisipha namalunga
• Ukuvuvukala emilenzeni yakho, emaqakaleni, noma ezinyaweni
• Ukuphefumula kanzima

Le miphumela emibi ejwayelekile ivamise ukuphatheka, futhi ithimba lakho lezempilo linganikeza amasu okusiza ukunciphisa umthelela wayo empilweni yakho yansuku zonke.

Kukhona neminye imiphumela emibi engavamile kodwa ebucayi edinga ukunakekelwa kwezokwelapha ngokushesha. Ngenkathi lokhu kuthinta iziguli ezimbalwa, kubalulekile ukuyazi:

• Izinkinga zamaphaphu, okuhlanganisa ukuvuvukala kwamaphaphu (pneumonitis)
• Umfutho wegazi ophezulu ovela kungazelelwe
• Ukushaya kwenhliziyo okuhamba kancane noma izinkinga zesigqi senhliziyo
• Ubuhlungu obukhulu bemisipha noma ubuthakathaka
• Ushintsho embonweni, okuhlanganisa umbono ongacacile noma ukuzwela ekukhanyeni
• Ubuhlungu besisu obukhulu noma obuqhubekayo
• Izimpawu ze-pancreatitis, njengobuhlungu obukhulu besisu obungase buqhubekele emhlane wakho

Xhumana nomhlinzeki wakho wezempilo ngokushesha uma uhlangabezana nanoma yiziphi zalezi zimpawu ezingathi sína. Ukungenelela ngokushesha kuvame ukuvimbela izinkinga futhi kukugcine uphephile ekwelashweni.

Eminye imiphumela emibi engavamile kodwa ebucayi ihlanganisa ukusabela okukhulu kwesikhumba nezinkinga zesibindi. Udokotela wakho uzokuqapha njalo ngezivivinyo zegazi ukuze abambe noma yiziphi izinkinga ngokushesha.

Ubani Ongafanele Athathwe I-Brigatinib?

I-Brigatinib ayifanele wonke umuntu, futhi i-oncologist yakho izohlola ngokucophelela ukuthi iphephile yini kuwe ngokusekelwe empilweni yakho yonke nomlando wezokwelapha. Lokhu kuhlola kusiza ukuqinisekisa ukuthi uthola inzuzo enkulu enobungozi obuncane.

Akufanele uthathe i-brigatinib uma wazi ukuthi unokungezwani komzimba emuthini noma kunoma yiziphi izithako zawo. Udokotela wakho uzobuyekeza umlando wakho wokungezwani komzimba ngaphambi kokukuchazela lo muthi.

Abantu abanezimo ezithile zenhliziyo bangase badinge ukuqashwa okukhethekile noma bangase bangabi ngabakhethi be-brigatinib. Lokhu kuhlanganisa labo abanezinkinga ezinkulu zesigqi senhliziyo noma ukusebenza kwenhliziyo okuncishiswe kakhulu.

Uma unezinkinga ezinkulu zesibindi noma izinso, udokotela wakho angase adinge ukulungisa umthamo wakho noma acabange ngezindlela zokwelapha ezingezinye. Ukuqashwa njalo kubaluleke kakhulu kulezi zimo.

Abesifazane abakhulelwe akufanele bathathe i-brigatinib ngoba ingalimaza ingane esakhula. Uma useminyakeni yokuzala, uzodinga ukusebenzisa izindlela zokulawula inzalo ezisebenzayo ngesikhathi sokwelashwa kanye nesikhathi esithile ngemva kokuyeka umuthi.

Igama Lomkhiqizo le-Brigatinib

I-Brigatinib ithengiswa ngaphansi kwegama lomkhiqizo elithi Alunbrig e-United States nakwamanye amazwe amaningi. Ungase ubone elinye igama emabhodleleni akho kadokotela noma emaphepheni omshwalense.

Lo muthi ukhiqizwa yi-Takeda Pharmaceuticals, futhi kuyisithako esifanayo esisebenzayo kungakhathaliseki ukuthi incwadi kadokotela wakho ithi

I-Ceritinib (Zykadia) enye inketho engasebenza kahle emithanjeni yomdlavuza esingamelana ne-crizotinib. Inezinye izinto ezingase zibe nemiphumela emibi, okungenzeka ukuthi zithandeka kwabanye abantu.

I-Alectinib (Alecensa) ithathwa njengephumelela kakhulu emdlavuzeni wamaphaphu we-ALK-positive futhi ingase ibe nemiphumela emibi embalwa kunezinketho ezithile. Ilungele ikakhulukazi ukwelapha umdlavuza oye wasabalala ebuchosheni.

I-Lorlatinib (Lorbrena) yakhelwe ukunqoba ukumelana nezinye izinto ezivimbela i-ALK futhi ingakwazi ukwelapha ngempumelelo ama-metastases obuchopho. Imele enye yezinketho ezintsha kulolu hlobo lwemithi.

Ingabe i-Brigatinib ingcono kune-Crizotinib?

Izifundo zemitholampilo zikhomba ukuthi i-brigatinib ingasebenza kangcono kune-crizotinib, ikakhulukazi ezigulini ezinomdlavuza osabalale ebuchosheni noma eziye zakha ukumelana nezinye izindlela zokwelapha. Kodwa-ke,

Umuthi ungabangela umfutho wegazi ophezulu nokushaya kwenhliziyo okuhamba kancane kwabanye abantu. Uma unesifo senhliziyo, odokotela bakho bazobheka le miphumela ngokucophelela futhi bangase balungise uhlelo lwakho lokwelashwa ngokufanele.

Iziguli eziningi ezinamathuba amancane kuya kwaphakathi nendawo ezinenkinga yenhliziyo zingawuthatha ngokuphepha umuthi i-brigatinib ngokubheka okufanele. Ithimba lakho lokunakekelwa kwezempilo lizohlola izinzuzo zokwelashwa komdlavuza ngokumelene nezingozi zenhliziyo ezingaba khona.

Kufanele Ngenzeni Uma Ngithatha I-Brigatinib Eningi Ngengozi?

Uma ngengozi uthatha i-brigatinib eningi kunaleyo ebekiwe, xhumana nomhlinzeki wakho wezempilo noma isikhungo sokulawula ubuthi ngokushesha. Ungalindi ukubona ukuthi ngabe izimpawu ziyavela yini, njengoba ukungenelela kwasekuqaleni kuhlala kungcono.

Ukuthatha i-brigatinib eningi kungase kuqhubeke nemiphumela emibi efana nesicanucanu, isifo sohudo, noma izinguquko zomfutho wegazi. Ukuba nebhodlela lomuthi nawe uma ushayela ucingo kungasiza abahlinzeki bezempilo ukuthi bakunikeze iseluleko esifanele kakhulu.

Ukuvimbela ukweqisa ngengozi, cabanga ukusebenzisa umhleli wamaphilisi noma ukusetha izikhumbuzi zocingo ukukusiza ukuthi ulandelele umthamo wakho wansuku zonke.

Kufanele Ngenzeni Uma Ngedlula Umthamo We-Brigatinib?

Uma udlula umthamo futhi sekudlule amahora angaphansi kwangu-12 kusukela ngesikhathi sakho esivamile, thatha umthamo owudlulile ngokushesha lapho ukhumbula. Uma sekudlule amahora angaphezu kwangu-12, weqa umthamo owudlulile bese uthatha umthamo wakho olandelayo ngesikhathi esivamile.

Ungalokothi uthathe imithamo emibili ngesikhathi esisodwa ukuze ulungise umthamo owudlulile, ngoba lokhu kungandisa ingozi yakho yemiphumela emibi. Kungcono ukugcina isimiso sakho esivamile siqhubeka.

Uma uvame ukukhohlwa imithamo, khuluma nethimba lakho lokunakekelwa kwezempilo mayelana namasu okukusiza ukuthi ukhumbule. Ukuthatha imithamo ngokuqhubekayo kusiza ukugcina amazinga aqinile omuthi emzimbeni wakho.

Ngingayeka Nini Ukuthatha I-Brigatinib?

Kufanele uyeke kuphela ukuthatha i-brigatinib ngaphansi kokuqondiswa ngudokotela wakho we-oncologist. Lesi sinqumo ngokuvamile sisekelwe ekutheni umuthi ulawula kahle kangakanani umdlavuza wakho nokuthi uzamukela kahle kangakanani noma yimiphi imiphumela emibi.

Udkt wakho uzosebenzisa izithwebuli ezivamile kanye nokuhlolwa kwegazi ukuqapha ukuthi imithi isasebenza yini. Uma umdlavuza wakho uqala ukukhula futhi noma uma uba nemiphumela emibi, bangase bakuncome ukuthi uyeke noma ushintshe uye ekwelashweni okuhlukile.

Noma ngabe uzizwa kahle, ukuyeka i-brigatinib ngaphandle kokugadwa ngudokotela kungavumela umdlavuza wakho ukuthi ukhule ngokushesha. Njalo xoxa nganoma yikuphi ukukhathazeka mayelana nokwelashwa kwakho neqembu lakho lezempilo kuqala.

Ngingakwazi yini ukuphuza utshwala ngenkathi ngithatha i-Brigatinib?

Ngenkathi kungekho ukusebenzisana okuqondile phakathi kwe-brigatinib notshwala, kuvamile ukunconywa ukuthi unciphise ukusetshenziswa kotshwala ngesikhathi sokwelashwa komdlavuza. Utshwala bungenza eminye imiphumela emibi ibe mibi futhi ingaphazamisa ikhono lomzimba wakho lokucubungula imithi.

Uma ukhetha ukuphuza utshwala ngezikhathi ezithile, xoxa lokhu neqembu lakho lezempilo kuqala. Bangakunika iseluleko sokuthi yini eningi, uma ikhona, engase iphephe ngokuya ngempilo yakho yonke kanye nohlelo lokwelashwa.

Khumbula ukuthi utshwala bungathinta nokusebenza kwesibindi sakho, futhi i-brigatinib idinga ukuqapha kwesibindi njalo. Ukugcina ukusetshenziswa kotshwala kuncane kusiza ekuqinisekiseni imiphumela eqondile yokuqapha.